Access Digital Health
CountriesInterventionsToolsAbout
Log in
← Interventions

Typhoid vaccination

Cost-effectiveness — what published models estimate per unit of health impact
$/DALY
—
no $/DALY
GiveWell
—
no GiveWell model
CE sources
1
Tier B · 15 studies
Source agreement
—
single source
Scope to country:All countries
Loading effectiveness evidence…
Cost-effectiveness

Estimates are sourced in their native units and shown for comparison, not as literal costs. Sources use different frameworks — see each card for what it represents and how it was derived.

Published study estimates ($/DALY)Tier B · context only

Tufts GHCEA · 15 studies, varied methods — explore the spread, not a single number.

Health-system
$1,401
median · n=6
Societal
$537
median · n=6
Mixed
$166
median · n=3
Filter the cohort
$454median of 15 studies · IQR $154–$1,708 · 2 cost-saving

No standardized benchmark available — only published studies with varied methods.

Data completeness: not assessed (no country selected) · Evidence confidence: not assessed (no country selected)
Delivery readiness is not currently shown. The country health-system view — workforce density, financing mix, service coverage — is being rebuilt as part of the scenario layer. The underlying indicators remain in the country pages.
The figures above are published benchmarks. To build an investment case for your own context — local unit costs, target population, coverage assumptions — model it directly. Select a country first to carry its context into the model.
Choose a country to model →
Looking for supply/market data for Typhoid vaccination? Select a country above, then open its intelligence page.